PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis
Cong-cong He, Ming-xing Lei, Jing-wei Jiang, Tao Zhang, Yu-ping Lai, Rui-qun Qi, Xing-Hua Gao · 2026
Read PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis by Cong-cong He, Ming-xing Lei, Jing-wei Jiang, Tao Zhang, Yu-ping Lai, Rui-qun Qi, Xing-Hua Gao (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13216575.txt.
Description
Cong-cong He and co-authors present a 2026 study of a matrix protein called PRELP that turns out to brake the inflammatory circuit driving psoriasis. The skin disease is powered by the cytokine IL-17A, and PRELP levels in lesions are oddly low.
Data mining showed PRELP scarce in untreated lesions but rebounding after IL-17A-blocking drugs. Experiments explained why: IL-17A itself suppresses PRELP in skin cells through the STAT3 factor. Restoring PRELP slowed skin cell growth, encouraged their death, damped inflammatory pathways, and cut IL-6 output, which in turn lowered local IL-17A production. Delivering PRELP to mouse skin eased psoriasis-like changes. The authors propose raising PRELP as a new treatment angle for Th17-driven disease.
Catalog record
| CREATOR | Cong-cong He, Ming-xing Lei, Jing-wei Jiang, Tao Zhang, Yu-ping Lai, Rui-qun Qi, Xing-Hua Gao |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |